Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Gastroenterology

• Publication date

  1985-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0016-5085(85)80004-4PMID 3882509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crossover designs and repeated measurements.

  1983cited by this paper
• Comparison of the Effects of Hepatic‐Aid and a Casein Modular Diet on Enceph‐alopathy, Plasma Amino Acids, and Nitrogen Balance in Cirrhotic Patients

  1983cited by this paper
• Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.

  1983cited by this paper
• Branched-chain amino acids vs lactulose in the treatment of hepatic coma

  1982cited by this paper
• Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.

  1982cited by this paper
• Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.

  1981cited by this paper
• Latent portasystemic encephalopathy

  1981cited by this paper
• Alcoholics' recovery from cerebral impairment as a function of duration of abstinence.

  1980cited by this paper
• Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet.

  1979cited by this paper
• Parenteral application of a special amino acid solution in the treatment of severe hepatic encephalopathy.

  1978cited by this paper
• Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study.

  1978cited by this paper
• Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.

  1978cited by this paper
• Chronic hepatic encephalopathy. A psychometrical study.

  1977cited by this paper
• False neurotransmitters and hepatic failure.

  1971cited by this paper
• Effects of ingestion of disproportionate amounts of amino acids.

  1970cited by this paper
• The determination of tryptophan in plasma, liver, and urine.

  1967cited by this paper
• The E.E.G. in hepatic encephalopathy.

  1963cited by this paper
• Fluorescence assay in biology and medicine

  1962cited by this paper
• Leucine-isoleucine antagonism in the rat

  1961cited by this paper
• Der Benton-Test

  1961cited by this paper
• The electroencephalograph in liver disease.

  1957cited by this paper
• Leucine, isoleucine and valine relationships in the rat.

  1956cited by this paper

• Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

  2026cites this paper
• Association of the protein-sodium dietary index with the incidence of clinical decompensation in patients with liver cirrhosis.

  2025cites this paper
• S2k-Leitlinie Klinische Ernährung in der Hepatologie

  2024cites this paper
• Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis

  2024cites this paper
• Is the Brain Undernourished in Alzheimer’s Disease?

  2022cites this paper
• EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.

  2022cites this paper
• Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis

  2021cites this paper
• Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis

  2021cites this paper
• Effect of Branched-Chain Amino Acid Infusion on In-Hospital Mortality of Patients With Hepatic Encephalopathy and End-Stage Kidney Disease: A Retrospective Cohort Study Using a National Inpatient Database.

  2021cites this paper
• Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review & Network Meta-analysis.

  2020cites this paper
• Outcomes of lactulose plus branched‐chain amino acid infusion and lactulose alone for hepatic encephalopathy: A retrospective cohort study using a national inpatient database

  2020cites this paper
• Hepatic Encephalopathy

  2019cites this paper
• Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease

  2019cites this paper
• Does Rifaximin Improve EEG and VEP in Egyptian Cirrhotic Patients with Minimal Hepatic Encephalopathy

  2018cites this paper
• 14 – Neurologic Consequences of Liver Disease

  2018cites this paper
•  Minimal hepatic encephalopathy in cirrhosis- how long to treat?

  2017cites this paper
• Branched-chain amino acids for people with hepatic encephalopathy.

  2017cites this paper
• Nutrition and the transplant candidate

  2017cites this paper
• Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?

  2016cites this paper
• articleImproved time to exhaustion following ingestion of the energy drink Amino Impact TM

  2015cites this paper
• Chapter 37 – Nutritional Aspects of Transplantation in Adults

  2015cites this paper
• Oral Branch Chain Amino Acids and Encephalopathy

  2015cites this paper
• Branched-chain amino acids for people with hepatic encephalopathy.

  2015cites this paper
• Central nervous system and pulmonary complications of end‐stage liver disease

  2015cites this paper
• Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy

  2015cites this paper
• Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis

  2014cites this paper
• Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.

  2013influential citation
• Smart applications for assessing minimal hepatic encephalopathy: Novelty from the app revolution

  2013cites this paper
• Prevalence of Minimal Hepatic Encephalopathy among Chronic Hepatitis C Patients and Assessment of their Response to Lactulose

  2012cites this paper
• Chapter 17 – Hepatic Encephalopathy

  2012cites this paper
• Consilience in sarcopenia of cirrhosis

  2012cites this paper
• Nutritional support for liver disease.

  2012cites this paper
• Traditional Management of Liver Disorders

  2012cites this paper
• Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

  2011cites this paper
• Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

  2011cites this paper
• Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy.

  2011cites this paper
• Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.

  2010cites this paper
• Improved time to exhaustion following ingestion of the energy drink Amino Impact™

  2010cites this paper
• Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure

  2010cites this paper
• Nutrition in hepatic encephalopathy.

  2010cites this paper
• Hepatic Encephalopathy: Treatment

  2010cites this paper
• Minimal hepatic encephalopathy.

  2009cites this paper
• Minimal hepatic encephalopathy

  2009cites this paper
• Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

  2009cites this paper
• 30 Management of Hepatic Encephalopathy : Seen and Unseen

  2009cites this paper
• The role of nutrition in hepatic encephalopathy

  2008cites this paper
• Role of branched‐chain amino acids in management of cirrhosis and hepatocellular carcinoma

  2008cites this paper
• [Nutrition in chronic liver diseases].

  2008cites this paper
• Treatment of minimal hepatic encephalopathy

  2008cites this paper
• Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis

  2007cites this paper
• Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

  2007cites this paper
• Role of branched-chain amino acids in liver disease: the evidence for and against

  2007cites this paper
• Nutrient Metabolism and Support in Normal and Diseased Livers

  2007cites this paper
• Minimal hepatic encephalopathy

  2007cites this paper
• Branched-chain amino acid enriched supplements as therapy for liver disease.

  2006cites this paper
• Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?

  2006cites this paper
• Branched-Chain Amino Acids: Metabolism, Physiological Function, and Application

  2006cites this paper
• Encefalopatía hepática mínima: Características, diagnóstico e implicaciones clínicas

  2006cites this paper
• Treatment of hepatic encephalopathy - systematic Cochrane reviews of randomised clinical trials

  2005cites this paper
• Branched-chain amino acids enhance the cognitive recovery of patients with severe traumatic brain injury.

  2005cites this paper
• Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.

  2005cites this paper
• ranched-Chain Amino Acids Enhance the Cognitive Recovery f Patients With Severe Traumatic Brain Injury

  2005cites this paper
• Branched-chain amino acids and brain function.

  2005cites this paper
• Cognition in liver disease

  2005cites this paper
• Branched-chain amino acid supplementation in patients with liver diseases.

  2005cites this paper
• Branched-Chain Amino Acids : Metabolism , Physiological Function , and Application Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease

  2005cites this paper
• Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis.

  2005cites this paper
• Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.

  2005cites this paper
• 33 – Nutritional Aspects of Adult Liver Transplantation

  2005cites this paper
• Branched chain amino acid supplements in liver disease.

  2005cites this paper
• High plasma branched-chain amino acids:aromatic amino acids ratio in children on the ketogenic diet: a mechanism in controlling epilepsy.

  2004cites this paper
• Nutritional therapy in cirrhosis

  2004cites this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cites this paper
• Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese.

  2004cites this paper
• LIVER FAILURE AND LIVER DISEASE Minimal Hepatic Encephalopathy Impairs Fitness to Drive

  2004cites this paper
• Branched-chain amino acids for hepatic encephalopathy.

  2003cites this paper
• Improvement of regional cerebral blood flow after treatment with branched‐chain amino acid solutions in patients with cirrhosis

  2003cites this paper
• Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives.

  2003cites this paper
• Nutritional and Clinical Evaluation of a Modified Soy Protein with Covalently Bound Branched-Chain Amino Acids in Cirrhotic Sprague-Dawley Rats

  2003cites this paper
• Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?

  2002cites this paper
• Nutritional Pharmacotherapy of Liver Cirrhosis for Prognosis and Improvement of Quality of Life

  2002cites this paper
• [Hepatic encephalopathy].

  2002cites this paper
• Treatment of hepatic encephalopathy.

  2001cites this paper
• [Hepatic encephalopathy].

  2001cites this paper
• Hepatic encephalopathy.

  2001cites this paper
• Correlation between a psychometric test and biochemical indices of hepatic encephalopathy in alcoholics.

  2000cites this paper
• Effect of Hemodiabsorption and Sorbent-Based Pheresis on Amino Acid Levels in Hepatic Failure

  2000cites this paper
• Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy

  2000cites this paper
• Hepatic Encephalopathy in Liver Cirrhosis

  2000cites this paper
• Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients.

  2000cites this paper
• [Guidelines of GASL for nutrition in liver diseases and liver transplantation].

  1999cites this paper
• Evaluating response to nutritional therapy using the branched‐chain amino acid/tyrosine ratio in patients with chronic liver disease

  1999cites this paper
• Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients

  1999cites this paper
• Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma.

  1999cites this paper
• Branched chain amino acids decrease tardive dyskinesia symptoms

  1999cites this paper
• LONG-TERM MANAGEMENT OF ALCOHOLIC LIVER DISEASE

  1998cites this paper
• Clinical and experimental aspects of hepatic encephalopathy

  1998cites this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cites this paper
• [Therapy of acute and chronic hepatic encephalopathy in patients with liver cirrhosis].

  1998cites this paper
• Subclinical hepatic encephalopathy: diagnosis, clinical implications, and intervention

  1997cites this paper